Exchange: NYSE·Updated 04:15 PM EDT
ENOV logo

ENOV Enovis Corp

$25.58
$0.37
(1.47%)
Today
Closed $25.58
$0.00
(0.00%)
After Hours
Reported EarningsAug 6
Mkt Cap$1.45B
Vol565,367.00

About ENOV

Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.
50

Neutral Sentiment

How do you feel about ENOV?

Advertisement|Remove ads.